Related Experiment Video
Updated: Jun 24, 2026
08:07
Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry
Published on: January 17, 2025
Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3
Lari Lehtiö1, Ann-Sofie Jemth, Ruairi Collins
1Structural Genomics Consortium, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17177 Stockholm, Sweden.
Journal of Medicinal Chemistry
|April 10, 2009
Summary
Poly(ADP-ribose) polymerases (PARPs) are key in DNA repair and cancer therapy. This study reveals structural insights into PARP-3 inhibitors, identifying KU0058948 as a potent inhibitor and guiding future drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Poly(ADP-ribose) polymerases (PARPs) play a crucial role in DNA repair pathways.
- PARP inhibition is a promising strategy in cancer drug therapy.
- Understanding PARP isoenzyme-specific inhibition is vital for targeted cancer treatments.
Purpose of the Study:
- To perform a structural and functional analysis of the human PARP-3 enzyme domain.
- To investigate the binding of various inhibitors to PARP-3.
- To identify key structural features for potent and selective PARP inhibitor design.
Main Methods:
- X-ray crystallography to determine the structures of PARP-3 in complex with inhibitors.
- Biochemical assays to assess the inhibitory activity of compounds against PARP-3.
- Structure-based drug design principles were applied.
Main Results:
- The study presents crystal structures of the human PARP-3 domain bound to several inhibitors.
- KU0058948 was identified as the most potent inhibitor of PARP-3 activity among those tested.
- Key structural determinants for potent inhibitor binding to PARP-3 were elucidated.
Conclusions:
- The structural insights gained provide a foundation for developing novel, isoenzyme-specific PARP inhibitors.
- Targeting PARP-3 with specific inhibitors like KU0058948 shows potential for cancer therapy.
- Further research can leverage these findings to design next-generation PARP-targeted drugs.
Related Concept Videos
00:58Eukaryotic RNA Polymerases
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:47Transcription Initiation
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
The promoters and enhancers and their accessory proteins allow tight regulation of...
00:43Bacterial RNA Polymerase
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
01:56Riboswitches
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...